Digital Health Commercialization Assessment

Turning Promising Healthcare Technology into Validated, Market-Ready Offerings

Digital health and MedTech organizations face a familiar challenge: strong technology does not automatically translate into commercial success. AI-enabled, virtual care, and connected solutions often stall because customer value is unclear, buyer dynamics are misunderstood, or go-to-market assumptions are untested. The result is slow adoption, inconsistent traction, or missed opportunities at critical moments.

The Offering

The Digital Health Commercialization Assessment is Bearing On Health’s flagship engagement. This focused, 8–12 week assessment combines structured market analysis with senior-level expert interviews to provide leadership teams with clear, defensible answers to the questions that determine commercial viability.

The output is not a generic market study. It is an executive-ready perspective designed to inform product strategy, positioning, and near-term go-to-market decisions.

Who This Is For

This engagement is designed for organizations facing high-stakes commercialization decisions, including:

• Digital Health Companies building new AI-driven, software-based, or connected health solutions

• MedTech Innovators evaluating expansion of connected devices into new clinical, buyer, or care-setting segments

• Startups and Investors assessing commercial viability, refining positioning, or preparing for fundraising, partnerships, or strategic reviews

Core Questions We Address

The assessment is structured to answer the questions leadership teams need clarity on before scaling:

• Customer Identification: Who is the highest-value customer, and who are the true economic and clinical buyers?

• Value Proposition & Differentiation:What specific “Jobs-to-be-Done” does the solution solve, and how is it meaningfully differentiated?

• Adoption & Friction: What workflow, staffing, regulatory, or incentive barriers must be addressed for real-world adoption?

• Go-to-Market Readiness: What does the MVP need to include, how should it be positioned, promoted and priced, and what early pathways to traction make sense?

What You Get

At the end of the engagement, clients receive:

• A clear articulation of target customers and buyer personas

• A validated value proposition grounded in real decision-maker input

• Practical guidance on product scope, positioning, and early commercialization strategy

• A shared, aligned point of view [MB12.1]leadership teams can use to move forward with confidence

Structure & Engagement Terms

• Timeline: 8–12 weeks

• Format: Fixed-fee, senior-led engagement

• Investment: Typically $25,000–$50,000, depending on scope and complexity

Every engagement is led personally by Adam Kaufman, PhD, with selective involvement from experienced industry experts as needed.